Berberine as Adjuvant Treatment for Schizophrenia Patients

News
1

Summary

One double-blind, randomized, placebo-controlled trial is designed to examine whether berberine added to current antipsychotic drugs could produce significantly greater efficacy in reducing atypical antipsychotic-induced metabolic syndrome. To achieve this objective, 120 patients with schizophrenia spectrum disorders (SSD) who have developed metabolic syndrome will be recruited and randomly assigned to receive additional treatment with placebo (n = 60) or berberine (n = 60, 1.2 g/day, 0.4 g, t.i.d.) for 12 weeks. The primary outcome is weight gain; other outcomes include body mass index (BMI), waist circumference, blood pressure, triglycerides (TG), total cholesterol, high-density lipoprotein (HDL), and low-density lipoprotein (LDL), fasting glucose, insulin, and insulin resistant index.

more info:

2

why has this study been going on for ten years and its still not on the market.
these guys just need something to do I’m starting to think. Maybe none of the scientific advances we read about are even true. IT MAKES YOU WONDER

3

If you look at the bottom of the link:

Butaclamol
A benzocycloheptapyridoisoquinolinol that has been used as an antipsychotic, especially in schizophrenia.

Wow! “benzocycloheptapyridoisoquinolinol”

Try pronouncing that one! Got to be one of the longest medicinal words out there!

4

You can purchase berberine online now in the USA.